60 mmHg or <20 mmHg, prompting timely medical consultation and filling a critical gap in home health management. This mode screens for atrial fibrillation (AFib) risk, pulse rate, and irregular heartbeats. A three-measurement protocol ensures the reliability of the results. Groundbreaking Technical Architecture: The A11 uses differentiated measurement technology. For blood pressure, it employs an oscillometric deflation method with a linear proportional valve, improving pressure control accuracy to 3-4 mmHg—far exceeding industry standards. For heart detection, it pioneers a constant pressure technology that breaks through traditional limitations. Intelligent Pressure Adaptation: A dual time-and-pressure adaptive mechanism automatically adjusts to the optimal pressure level for each individual (such as the elderly), reducing discomfort and measurement errors. Enhanced Comfort: The constant pressure method significantly reduces the oppressive feeling of repeated inflation and deflation, making measurements smoother and more efficient. Expanded Health Insights: The inclusion of pulse pressure provides a more in-depth assessment of vascular health than single-function monitors can offer. The design of the A11 embodies a multi-faceted approach to sustainability: Health Sustainability: Early screening for critical indicators like AFib and elevated pulse pressure promotes a "prevention-first" approach to health, reducing the risk of major cardiovascular events and the associated healthcare burden. " />

2025

A11

Entrant

Shenzhen Jamr Technology Co., Ltd.

Category

Provider & Services - Healthcare

Client's Name

Country / Region

China

The A11 is a revolutionary home health monitoring device that transcends the single-function limitations of traditional blood pressure monitors by innovatively introducing the "One Device, Dual-Measurement" concept. The A11 is not just a high-precision blood pressure monitor, but also a professional heart health screening tool. It seamlessly integrates the two core functions of blood pressure measurement and cardiac detection. By incorporating pulse pressure monitoring and a pioneering constant pressure heart detection algorithm, it offers users (especially middle-aged and elderly individuals) an unprecedented, comprehensive, convenient, and cost-effective solution for at-home cardiovascular health management. This mode accurately measures systolic pressure, diastolic pressure, and pulse rate. It also features a pulse pressure display, providing a key indicator for at-home monitoring of cardiovascular risks like arterial sclerosis. The system includes a built-in clinical reference range (30-40 mmHg) and alerts the user when pulse pressure is consistently >60 mmHg or <20 mmHg, prompting timely medical consultation and filling a critical gap in home health management. This mode screens for atrial fibrillation (AFib) risk, pulse rate, and irregular heartbeats. A three-measurement protocol ensures the reliability of the results. Groundbreaking Technical Architecture: The A11 uses differentiated measurement technology. For blood pressure, it employs an oscillometric deflation method with a linear proportional valve, improving pressure control accuracy to 3-4 mmHg—far exceeding industry standards. For heart detection, it pioneers a constant pressure technology that breaks through traditional limitations. Intelligent Pressure Adaptation: A dual time-and-pressure adaptive mechanism automatically adjusts to the optimal pressure level for each individual (such as the elderly), reducing discomfort and measurement errors. Enhanced Comfort: The constant pressure method significantly reduces the oppressive feeling of repeated inflation and deflation, making measurements smoother and more efficient. Expanded Health Insights: The inclusion of pulse pressure provides a more in-depth assessment of vascular health than single-function monitors can offer. The design of the A11 embodies a multi-faceted approach to sustainability: Health Sustainability: Early screening for critical indicators like AFib and elevated pulse pressure promotes a "prevention-first" approach to health, reducing the risk of major cardiovascular events and the associated healthcare burden.

Credits

Tan Wenlong
Hu Yitao
Wei Lina
Provider & Services
2025
INTOUS RanRan AK4000, Healthcare Awards Winner

Entrant

Beverly Trading (Shenzhen) Co., Ltd.

Category

Provider & Services - Healthcare

Country / Region

China

Provider & Services
2025
GUIDE FOR PROFESSIONALS: Supporting patients with chronic kidney disease facing food insecurity, Healthcare Awards Winner

Entrant

American Kidney Fund

Category

Provider & Services - Education

Country / Region

United States

Achievement of the Year
2025
DSCSA (Drug Supply Chain Security Act) compliance for pharmaceutical manufacturers, Healthcare Awards Winner

Entrant

Gaurang Bhavsar

Category

Achievement of the Year - Healthcare Leadership Awards of the Year

Country / Region

United States

Advertising
2025
Evolus Academy Aesthetics Education on Facial Anatomy, Healthcare Awards Winner

Entrant

Alexander & Turner Inc. Medical Illustration Studio

Category

Advertising - Illustration / Graphic

Country / Region

United States